Chlorpromazine Induced Cataract in a female patient: A Case Report
DOI:
https://doi.org/10.3126/jpan.v11i2.57688Keywords:
cataract, chlorpromazine, schizophrenia, antipsychotic agentsAbstract
Tablet Chlorpromazine is a commonly used, affordable antipsychotic in developing countries. Chlorpromazine induced cataract and corneal pigmentation was first described by Greiner & Berry in 1964 but in the context of Nepal, there is no available literature or cases reported to date. Despite having a myriad of side effects, it is still used frequently in developing countries due to its cost-effectiveness. In this light, we report a case of a 43-year-old female with a diagnosis of Schizophrenia who had been treated with Tab. Chlorpromazine for 25 years. She lost to follow-up and presented at the OPD with cataract in bilateral eyes.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Journal of Psychiatrists' Association of Nepal
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.